AR040301A1 - Composicion osmotica expansible y suspension para revestimiento mejoradas - Google Patents

Composicion osmotica expansible y suspension para revestimiento mejoradas

Info

Publication number
AR040301A1
AR040301A1 ARP030102341A ARP030102341A AR040301A1 AR 040301 A1 AR040301 A1 AR 040301A1 AR P030102341 A ARP030102341 A AR P030102341A AR P030102341 A ARP030102341 A AR P030102341A AR 040301 A1 AR040301 A1 AR 040301A1
Authority
AR
Argentina
Prior art keywords
weight
suspension
expansible
improved coating
osmotic composition
Prior art date
Application number
ARP030102341A
Other languages
English (en)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AR040301A1 publication Critical patent/AR040301A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Paper (AREA)

Abstract

Reivindicación 1: Una suspensión para revestimiento que comprende: un osmopolímero; un agente osmótico; un formador de película, en donde la suspensión para revestimiento incluye entre aproximadamente 5% en peso y aproximadamente 7% en peso del formador de película; y un sistema de disolventes de dos partes. Reivindicación 17: La suspensión para revestimiento de acuerdo con la reivindicación 1, en donde el osmopolímero, el agente osmótico y el formador de película representa aproximadamente 16% en peso a aproximadamente 20% en peso de la suspensión para revestimiento, incluyendo la suspensión para revestimiento aproximadamente 5% en peso a aproximadamente 7% en peso de formador de película, aproximadamente 3% en peso a aproximadamente 6,2% en peso de osmopolímero y aproximadamente 5,3% a aproximadamente 10% de agente osmótico.
ARP030102341A 2002-06-28 2003-06-27 Composicion osmotica expansible y suspension para revestimiento mejoradas AR040301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39277502P 2002-06-28 2002-06-28

Publications (1)

Publication Number Publication Date
AR040301A1 true AR040301A1 (es) 2005-03-23

Family

ID=30000934

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030102341A AR040301A1 (es) 2002-06-28 2003-06-27 Composicion osmotica expansible y suspension para revestimiento mejoradas

Country Status (15)

Country Link
US (1) US7338663B2 (es)
EP (1) EP1528913A1 (es)
JP (1) JP2005532374A (es)
KR (1) KR20050071375A (es)
CN (1) CN1678292A (es)
AR (1) AR040301A1 (es)
AU (1) AU2003248868A1 (es)
CA (1) CA2490683A1 (es)
IL (1) IL165864A0 (es)
MX (1) MXPA05000207A (es)
NO (1) NO20050181L (es)
NZ (1) NZ537343A (es)
TW (1) TW200414900A (es)
WO (1) WO2004002450A1 (es)
ZA (1) ZA200500826B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
EP1896002A4 (en) * 2005-06-27 2009-11-25 Biovail Lab Int Srl BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
CA2655596C (en) * 2006-06-27 2011-10-25 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
US7785478B2 (en) * 2007-08-08 2010-08-31 General Electric Company Method for controlling protozoa that harbor bacteria
US7824557B2 (en) * 2007-08-08 2010-11-02 General Electric Company Method for controlling microbial biofilm in aqueous systems
US20110052655A1 (en) * 2007-08-08 2011-03-03 Wilson Kurt Whitekettle Methods and vesicles for controlling protozoa
CN102871982B (zh) 2012-10-16 2014-09-10 中国科学院上海药物研究所 一种药物渗透泵制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36472A (en) * 1862-09-16 Cttlvebt
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
CA2354472C (en) * 1998-12-17 2009-02-24 Alza Corporation Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system

Also Published As

Publication number Publication date
AU2003248868A1 (en) 2004-01-19
EP1528913A1 (en) 2005-05-11
CA2490683A1 (en) 2004-01-08
NO20050181L (no) 2005-01-12
MXPA05000207A (es) 2005-06-06
IL165864A0 (en) 2006-01-15
WO2004002450A1 (en) 2004-01-08
KR20050071375A (ko) 2005-07-07
US7338663B2 (en) 2008-03-04
ZA200500826B (en) 2006-08-30
CN1678292A (zh) 2005-10-05
US20040058002A1 (en) 2004-03-25
TW200414900A (es) 2004-08-16
JP2005532374A (ja) 2005-10-27
NZ537343A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
AR029737A1 (es) Concentrados de anticongelantes a base de amidas y composiciones refrigerantes que los comprenden, para la proteccion del magnesio y aleaciones de magnesio
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
AR015900A1 (es) Una formulacion farmaceutica que comprende voriconazol o un derivado farmaceuticamente aceptable del mismo y un derivado de ciclodextrina.
AR040301A1 (es) Composicion osmotica expansible y suspension para revestimiento mejoradas
HRP20050828A2 (en) Uv stable transdermal therapeutic plaster
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
ECSP22009719A (es) Mezclas que comprenden plaguicidas de indazol
PE20011122A1 (es) DERIVADOS DE PURINA-2-ILCARBOXAMIDA COMO AGONISTAS SELECTIVOS DEL RECEPTOR A2a DE LA ADENOSINA
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
ES2159591T3 (es) Composicion de liberacion controlada.
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
RS50759B (sr) Formulacije gela 4-hidroksi-tomoksifena
CO5231147A1 (es) Composicion congelante
PT1185594E (pt) Composicao adesiva que compreende microcapsulas termoexpansiveis
CO6382164A2 (es) Solucion acuosa para la preservacion de tejidos y organos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
PE20040875A1 (es) Composiciones para el cuidado bucal
ES2093682T3 (es) Composiciones de isotiazolona diluibles en agua.
AR022294A1 (es) Combinaciones de productos activos fungicidas.
UY38055A (es) Composiciones oftálmicas de compuestos de bencimidazol para uso unico diario
CO4750591A1 (es) Procedimiento de lucha contra los insectos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal